What i+MED Laboratories Company does

i+MED Laboratories Co., Ltd. (บริษัท ไอเมด ลาบอราทอรี่ จำกัด) is a Bangkok-headquartered Thai medical device company founded in 2001, operating as both a manufacturer and a domestic distributor of comprehensive medical devices. Its own-manufactured portfolio centers on rapid diagnostic test kits built on Chromatographic Immunoassay (lateral flow) technology, designed to detect antibodies, antigens, or hormones in human, animal, plant, and food samples. Flagship products include the i+LAB αTHAL IC Strip for alpha thalassemia screening, infectious disease panels (respiratory, gastrointestinal, vector-borne, zoonotic, COVID-19), tumor marker, fertility, sexually transmitted disease, and drug-of-abuse rapid tests, plus a Rh blood group typing kit co-developed with Chulalongkorn University.

The company's distribution arm carries third-party analyzers (chemistry, immunology, hematology, urine, electrolyte, HbA1C, immunohistochemistry), HAIER BIOMEDICAL life science equipment (cryogenic and biomedical freezers, biological safety cabinets, air purification sterilizers), and laboratory quality control products (IQC and EQA). A complementary IT Solutions line offers the Digital Forensic Solution (cloud-based forensic case evidence management), Pathology Case Management software, Sample Storage inventory software, and IoT-enabled laboratory monitoring. Manufacturing is conducted under EN ISO 13485:2016 certification and GMP for Medical Devices standards.

i+MED generates revenue primarily through hardware sales of its own rapid diagnostic kits and distributed instruments, with a smaller recurring software component. Go-to-market is sales-led and direct, targeting public and private hospitals, independent medical laboratories, life science research institutions, and government/military healthcare buyers (including the Royal Thai Army). Marketing relies on participation in healthcare exhibitions (ACMTT, Thailand LAB INTERNATIONAL, pathology and clinical microbiology conferences), a corporate website with Thai/English versions, and social channels (Facebook, LINE, Instagram, LinkedIn). Pricing is quote-based and not publicly disclosed, with multi-year contracts available to institutional customers.

Name

i+MED Laboratories Company

Legal name

บริษัท ไอเมด ลาบอราทอรี่ จำกัด (i+MED Laboratories Co., Ltd.)

Website

https://imed.co.th

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

101–250 employees

Short description

i+MED Laboratories is a Thai medical device manufacturer and distributor producing Chromatographic Immunoassay rapid diagnostic test kits and distributing third-party analyzers, HAIER BIOMEDICAL life science equipment, and laboratory software to hospitals, medical laboratories, and government healthcare agencies in Thailand.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Devices

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL)

akta.pro secondary industries

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH)

Keywords

• Rapid diagnostic test kits
• Medical device distribution
• Chromatographic immunoassay
• Clinical chemistry analyzers
• Biomedical laboratory freezers

Headquarters

HQ city

Bangkok

HQ country

Thailand

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Rapid Diagnostic Test Kits Manufacturing & Sales: Manufacturing and distribution of rapid diagnostic test kits for medical purposes using Chromatographic Immunoassay principle. Tests detect antibodies, antigens, or hormones in samples from humans, animals, plants, or substances found in food and raw materials. Products include alpha thalassemia screening, infectious disease tests, fertility tests, drug abuse tests, and tumor markers.
2. Medical Instruments Distribution: Distribution of medical instruments from leading brands including Chemistry Analyzers, Immunology Analyzers, Hematology Analyzers, Urine Analyzers, Electrolyte Analyzers, HbA1C Analyzers, and Immunohistochemistry Analyzers.
3. Medical Information Systems (IT Solutions): Providing IT solutions and software for medical information systems and technologies, including digital forensic solutions and laboratory management software.
4. Life Science Products: Distribution of life science equipment including biomedical freezers (-86°C, -40°C, -30°C, -25°C), biosafety cabinets, and air purification sterilizers under HAIER BIOMEDICAL brand.
5. Quality Control Products: Supply of IQC (Internal Quality Control) and EQA (External Quality Assessment) products for laboratory quality assurance.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

i+MED Laboratories Co., Ltd. manufactures rapid diagnostic test kits using Chromatographic Immunoassay lateral flow technology to detect antibodies, antigens, or hormones in human, animal, plant, and food samples. The company also distributes medical instruments (Chemistry, Immunology, Hematology, Urine, Electrolyte, HbA1C, and Immunohistochemistry Analyzers) and HAIER BIOMEDICAL life science equipment, and provides medical IT solutions for forensic and pathology case management.

Product overview

i+MED Laboratories Company operates as both a manufacturer and distributor of comprehensive medical devices, organized into two main pillars: (1) Own-manufactured products including rapid diagnostic test kits using Chromatographic Immunoassay technology, and (2) Distributed medical instruments and Life Science equipment. The rapid diagnostic portfolio spans multiple categories — Alpha Thalassemia screening strips (i+LAB αTHAL IC Strip), rapid tests for respiratory infections, gastrointestinal diseases, vector-borne diseases, zoonosis, infectious diseases, tumor markers, fertility, sexually transmitted diseases, and drug of abuse — all interpreted via lateral flow color band reading. The instrument distribution arm covers seven analyzer types: Chemistry Analyzer, Immunology Analyzer, Hematology Analyzer, Urine Analyzer, Electrolyte Analyzer, HbA1C Analyzer, and Immunohistochemistry Analyzer. Point-of-Care Testing includes Rapid Molecular Testing (Influ/RSV/StepA) and Rapid Test with Reader (Influenza). The Life Science lineup includes biomedical freezers (at -150°C, -40°C, -30°C, -25°C), biological safety cabinets, standard biosafety cabinets, and air purification sterilizers from HAIER BIOMEDICAL. IT Solutions provide software for pathology/forensic case management and laboratory inventory (Sample Storage). R&D has produced a blood type grouping test kit (Rh system) developed jointly with Chulalongkorn University.

Differentiator

Problem solved

Functional benefit

Brands

• i+LAB: Internal brand for laboratory products including i+LAB αTHAL IC Strip for alpha thalassemia screening
• i+MED Life Science
• i+LAB αTHAL IC Strip

Products and services

• i+LAB αTHAL IC Strip

Quantifiable outcome

• COVID-19 test kit donation of 700,000 THB value to Faculty of Medicine Vajira Hospital for community screening

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Chulalongkorn University (จุฬาลงกรณ์มหาวิทยาลัย)coreStrategic or Co-development PartnerJoint research partnership with Chulalongkorn University for developing Rh blood type system test kits (D, C, E, c and e antigens). The test kit is low-cost, easy to use, provides rapid results, and can be read with the naked eye without centrifuge equipment.
• HAIER BIOMEDICALcoreChannel Partner/ Reseller/ Distributori+MED distributes HAIER BIOMEDICAL products in Thailand including -150°C Cryo Freezers, Biomedical Freezers (-25°C, -30°C, -40°C), Biological Safety Cabinets, Air Purification Sterilizers, and Sample Storage software. Products featured at Thailand LAB exhibitions.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• EKF Diagnostics: UK-listed diagnostics company with a portfolio spanning HbA1c analyzers, rapid test kits, and point-of-care devices. Mid-cap peer with similar manufacturer-plus-distributor model and focus on emerging market distribution channels.
• ARKRAY: Japan-based diagnostics manufacturer with strong presence in urine analyzers, HbA1c analyzers, and clinical chemistry — overlapping directly with several analyzer categories i+MED distributes in Thailand. Comparable mid-size Asian IVD player with proprietary + distribution mix.
• Meril Diagnostics: Indian medical device manufacturer and distributor offering IVD reagents, rapid test kits, and laboratory analyzers across emerging Asian markets. Highly comparable emerging-market IVD manufacturer-distributor with similar product breadth and GTM motion.
• SD Biosensor: South Korea-headquartered manufacturer and distributor of rapid diagnostic test kits (including COVID-19, infectious disease, and cardiac markers) using immunochromatography. Closely mirrors i+MED's manufacturer-plus-distributor hybrid model and is a direct Asian mid-market IVD peer.
• Humasis: Korean IVD manufacturer specializing in rapid diagnostic kits (infectious disease, fertility, drugs of abuse) and POCT devices. Comparable in product format (lateral flow), customer base (hospitals/labs/government), and Asian mid-market positioning to i+MED.

Broad incumbents

• Bio-Rad Laboratories: Global life science and clinical diagnostics company offering quality controls (IQC/EQA programs — directly overlapping i+MED's QC product line), clinical chemistry, and immunology systems. Major incumbent competing for Thai hospital lab contracts.
• Abbott Rapid Diagnostics: Global IVD leader with the BinaxNOW and Panbio rapid test franchises and extensive chemistry/immunoassay analyzer portfolio. Competes with i+MED across most product categories in Thai hospital tenders but operates at vastly larger scale with broader geographic reach.
• Roche Diagnostics: Global IVD leader with the cobas analyzer platform, Elecsys immunoassays, and rapid test presence in Thailand. Represents the dominant incumbent competitor for i+MED's chemistry/immunology distribution and any proprietary kit expansion.
• QuidelOrtho: Major US-headquartered IVD company with strong rapid test (Sofia) and immunoassay franchises competing for Thai hospital, military, and government health contracts. Larger incumbent peer sharing similar customer verticals.

Regional players

• Diagnocine: Indonesia-based IVD manufacturer and distributor serving the broader Southeast Asian market with rapid test kits and laboratory reagents. Most comparable regional peer by geography and scale, with active distribution across ASEAN markets i+MED has yet to enter.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/i-med-laboratories-company-limited
• Instagraminstagram.com/imed_laboratories

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about i+MED Laboratories Company